Actualización en medicina de familiapatología periodontal
- M.C. López Silva 1
- P. Diz-Iglesias 2
- J.M. Seoane-Romero 2
- V. Quintas 2
- F. Méndez-Brea 2
- P. Varela-Centelles 2
- 1 CS Praza do Ferrol, EOXI Lugo, Cervo, e Monforte de Lemos, Servizo Galego de Saúde, Lugo, España
- 2 Universidad de Santiago de Compostela, Santiago de Compostela, A Coruña, España
ISSN: 1138-3593
Ano de publicación: 2017
Número: 2
Páxinas: 141-148
Tipo: Artigo
Outras publicacións en: Semergen: revista española de medicina de familia
Resumo
About 85-94% of the Spanish adults older than 35 experience gum problems, and about 15-30% suffer from periodontitis, being severe in up to 5-11% of them. Unlike other inflammatory conditions, periodontal disease rarely causes discomfort, or limits life or causes functional limitations until its advanced stages, when clinical signs and symptoms arise (gingival recession, pathological teeth migration, or mobility). Lack of knowledge about the disease, together with the idea that tooth loss is linked to ageing, frequently results in a late diagnosis, requiring extensive treatments with a worse prognosis. At Primary Care level, there is series of drugs have been related to periodontal disease (anticonvulsants, immunosuppressive drugs, and calcium channel blockers) as secondary effects, which vary as regards their frequency and severity depending of the amount of accumulated plaque. Stress and depression have also been reported to alter the immune response and to increase the inflammatory response as well as periodontal susceptibility. Certain systemic conditions, such as diabetes mellitus, cardiovascular disorders, respiratory diseases, as well as low-weight pre-term birth, have also been linked to periodontitis.